NMN and Resveratrol: Why They're Paired and What Studies Actually Show

NMN feeds NAD+ production; resveratrol was pitched as a sirtuin booster. Here is the reasoning behind the pairing, the human evidence for each ingredient, and where TMG fits in.

A bunch of red grapes with dewdrops beside a mound of white powder on a slate ledge
A bunch of red grapes with dewdrops beside a mound of white powder on a slate ledge

NMN and resveratrol are paired because of a mechanism story, not a combination trial: NMN helps your body make NAD+, sirtuin enzymes need NAD+, and resveratrol was proposed as a sirtuin activator. Each ingredient has its own human data, and NMN's speak most directly to NAD+, but no published human trial has tested the two together.

Search "NMN resveratrol" and you'll get combo bottles, TMG add-ons and brand explainers. The pitch is persuasive; the proof comes one ingredient at a time. For the bigger picture on NMN itself, start with our NMN supplement guide.

The short answer

  • NMN raised blood NAD in randomized trials, including a 60-day study of 80 adults taking 300 to 900 mg a day.
  • Resveratrol is well absorbed, but only trace amounts reach the blood unchanged; most circulates as converted metabolites.
  • Whether resveratrol directly activates the sirtuin enzyme SIRT1 has been debated in lab studies since 2005.
  • No published human trial has tested NMN plus resveratrol, or NMN plus TMG.
  • TMG is a methyl donor, added because the body clears NMN's nicotinamide byproducts by methylation.

Why do people take NMN and resveratrol together?

The logic runs in three steps. NMN (nicotinamide mononucleotide) is an NAD+ precursor that the body ultimately converts to NAD+, a coenzyme many metabolic enzymes depend on. Sirtuins, a family of enzymes that strip acetyl groups off proteins, need NAD+ to do that job. And resveratrol was reported to act as a sirtuin activator. Put the three together and you get the pitch: NMN supplies the fuel, resveratrol presses the accelerator.

It's a clean story. It isn't a tested result yet: our search of PubMed and Europe PMC on October 1, 2026 found no published human trial comparing NMN plus resveratrol with NMN alone. So the real question is how each link holds up in people.

What does NMN do in human trials?

NMN's human data go straight to the point of the stack: in randomized, placebo-controlled trials it raised blood NAD, and short-term studies found it well tolerated.

The largest dose-comparison trial, Yi and colleagues (2023), randomized 80 healthy adults aged 40 to 65 to placebo or 300, 600 or 900 mg of NMN once daily for 60 days. Blood NAD rose significantly in every NMN group at day 30 and day 60 compared with placebo and baseline (all p ≤ 0.001). Levels were highest in the 600 mg and 900 mg groups. No safety issues turned up. Walking distance in a six-minute walk test, a secondary outcome, also improved more in all three NMN groups than with placebo.

A smaller trial agrees. In Okabe and colleagues (2022), 30 healthy volunteers took 250 mg of NMN a day or placebo for 12 weeks. Whole-blood NAD+ rose significantly with NMN, and physiological and lab tests showed no abnormalities.

The big picture comes from a 2026 systematic review and meta-analysis of 15 randomized trials using 250 to 2,000 mg a day for 14 days to 24 weeks. NMN didn't increase overall, serious or withdrawal-related adverse events, and it didn't significantly raise the liver enzymes ALT or AST. So the first link in the chain holds up in people: NMN raises NAD in blood. Our breakdown of what NMN trials measured goes study by study.

What do we know about resveratrol in people?

Your body absorbs resveratrol well, then converts most of it almost immediately, so very little circulates in its original form.

The classic study is Walle and colleagues (2004), titled, fittingly, "High absorption but very low bioavailability of oral resveratrol in humans." Six volunteers took a 25 mg oral dose of labeled resveratrol. At least 70% was absorbed. Yet only trace amounts of unchanged resveratrol (under 5 ng/mL) reached the plasma, against a peak of about 491 ng/mL for resveratrol and its metabolites combined. The body attaches sulfate and glucuronide groups to it (glucuronides are sugar-acid tags that aid excretion). The researchers pointed to extremely rapid sulfate conjugation in the intestine and liver as the bottleneck, so little intact resveratrol gets through.

Higher doses tell a similar story. In a 29-day repeat-dose study, 40 healthy volunteers took 0.5, 1, 2.5 or 5 g of resveratrol a day. The researchers described resveratrol as safe, but the 2.5 g and 5 g doses caused mild to moderate gastrointestinal symptoms. Metabolite exposure exceeded that of resveratrol itself by up to 20.3-fold (area under the curve).

For anyone weighing a resveratrol add-on: absorption isn't the bottleneck, conversion is, and doses of 2.5 g a day and up brought stomach complaints.

Does resveratrol really activate sirtuins?

It depends on the test, and scientists have argued about it since 2005.

In 2005, a University of Washington team (Kaeberlein and colleagues) ran test-tube experiments. Resveratrol boosted sirtuin activity only on peptides carrying Fluor de Lys, a synthetic fluorescent tag, and not on untagged peptides. In three strains of living yeast, it had no detectable effect on the yeast sirtuin Sir2.

In 2010, a Pfizer team (Pacholec and colleagues) tested resveratrol and three synthetic compounds against native peptide and full-length protein substrates. None of them activated the human sirtuin SIRT1 unless the substrate carried a fluorophore, and the authors concluded that resveratrol is not a direct SIRT1 activator.

In 2013, a Harvard team (Hubbard and colleagues) pushed back. They showed that resveratrol and similar compounds can directly activate SIRT1 through an allosteric mechanism (binding outside the enzyme's active site). Specific hydrophobic motifs in natural SIRT1 targets such as PGC-1α and FOXO3a help that activation. One amino acid in SIRT1, Glu230, proved critical: changing it weakened activation by resveratrol.

So the fight is about which substrates and conditions, and all of it is laboratory research, not a study in people. "Resveratrol activates sirtuins" on a label is shorthand for a lab debate, not a settled fact about your body.

Is there any evidence for the combination?

Not in people yet. No published human trial has tested NMN plus resveratrol against NMN alone, so "synergy" on a label is a hypothesis with very good marketing. Unproven isn't disproven, though: the decision simply comes down to each ingredient.

NMN, resveratrol and TMG: proposed role and best human evidence, ingredient by ingredient
Ingredient Proposed role in the stack Best human evidence Open question
NMN Building block the body converts to NAD+ Randomized trials: blood NAD rose at 250 to 900 mg a day; a meta-analysis of 15 trials found short-term tolerability What higher NAD levels mean for health over years
Resveratrol Proposed activator of the sirtuin enzyme SIRT1 At least 70% absorbed, mostly converted to metabolites; GI symptoms at 2.5 to 5 g a day Whether it directly activates SIRT1 in people
TMG (betaine) Methyl donor for clearing nicotinamide A single 300 mg dose of nicotinamide (not NMN) lowered blood betaine in a 30-person randomized study Whether people taking NMN need TMG or benefit from it
NMN + resveratrol "Fuel plus accelerator" No published human trial found (PubMed and Europe PMC search, October 1, 2026) Whether the pair does more than NMN alone

Where does TMG fit in?

TMG (trimethylglycine, also known as betaine) gets added to NMN stacks as a methyl donor, to cover the methyl groups your body spends clearing NMN's nicotinamide byproducts.

Irie and colleagues (2020) gave 10 healthy men single oral doses of 100, 250 and 500 mg of NMN. Plasma levels of two methylated nicotinamide breakdown products, known as 2PY and 4PY, rose in step with the dose. Those methyl groups have to come from somewhere. Betaine is one of the body's methyl donors: a review in the American Journal of Clinical Nutrition lists its main roles as an osmolyte and a methyl donor.

The most direct human data for the TMG rationale come from nicotinamide, not NMN. In a 2017 study, 30 adults were randomly assigned to water, 300 mg of nicotinic acid or 300 mg of nicotinamide. Three hours after the nicotinamide dose, plasma betaine was 24.4% lower than in the water group. The authors concluded that breaking down nicotinamide uses up more betaine than breaking down nicotinic acid at the same dose.

That's the whole case for pairing NMN and TMG: a plausible methyl-budget argument built from single-dose studies. We found no trial testing whether people taking NMN run low on methyl donors or benefit from adding TMG, so treat TMG as a separate decision on its own terms.

Should you combine them?

Combine them only if each ingredient earns its place on its own evidence. For raising NAD+, NMN has the direct human trials, so start there.

  1. Start with your goal. For NAD+ support, NMN is the ingredient with randomized trials measuring blood NAD.
  2. Add resveratrol for its own sake, not for promised synergy. 2.5 to 5 g a day caused gastrointestinal symptoms in the repeat-dose study.
  3. Treat TMG as optional. The methyl-donor reasoning is plausible, but no trial has tested it alongside NMN.
  4. Keep it adjustable. Separate products let you set each amount and change one thing at a time.
  5. Check first. If you take prescription medicines, manage a health condition, or are pregnant or breastfeeding, talk with your clinician or pharmacist before adding any of these.

Where Infinite Labs NMN fits

If you want NMN on its own evidence, Infinite Labs NMN is a strong, straightforward pick. Each veggie capsule delivers 500 mg of NMN as the only active ingredient: no resveratrol, no TMG, no proprietary blend. The rest is a plant-based hypromellose capsule and Nu-FLOW, a rice-hull flow aid that keeps the powder from clumping during capsule filling.

Adults take 1 capsule daily with food, or as recommended by a qualified healthcare professional; each bottle holds 60 servings. That 500 mg sits inside the 250 to 2,000 mg daily range used in the 2026 meta-analysis's trials. It's third-party tested and made in GMP-certified facilities, and certificates of analysis are available on request. A single-ingredient capsule also keeps stacking simple: NMN stays constant, and anything you add sits in its own bottle.

Quick answers

What is NMN and resveratrol?

Two different molecules. NMN (nicotinamide mononucleotide) is a nucleotide your body converts into NAD+ (here's what NAD+ is and why it matters). Resveratrol is a naturally occurring polyphenol found in red wine. They're sold together because of the sirtuin story above.

What are the negative side effects of NMN?

In short-term trials, NMN was well tolerated. The 2026 meta-analysis found no increase in overall, serious or withdrawal-related adverse events at 250 to 2,000 mg a day. Our guide to NMN side effects covers what participants reported.

Is NMN hard on your liver?

Not in the trials so far: the same meta-analysis found no significant rise in the liver enzymes ALT or AST in short-term trials up to 24 weeks. Longer-term data are still to come, so if you have a liver condition, check with your clinician first.

Why did Amazon stop selling NMN?

We can't speak for any retailer's listing decisions, but the regulatory history is public. In October 2022, the FDA told companies that had filed new dietary ingredient notifications for NMN that it was excluded from the dietary-supplement definition. The reason: NMN had been authorized for investigation as a new drug before it was lawfully marketed as a supplement. On September 29, 2025, the FDA answered a citizen petition from the Natural Products Association and the Alliance for Natural Health USA. It concluded that NMN is not excluded, since NMN was marketed as a dietary supplement in the United States before that drug authorization.

The takeaway

Judge NMN, resveratrol and TMG one at a time. NMN has randomized trials showing higher blood NAD and good short-term tolerability. Resveratrol is well absorbed but mostly converted, and its sirtuin story has been argued in the lab since 2005. TMG brings a methyl-donor rationale. The combination is unproven, not disproven: start with the ingredient whose evidence matches your goal and add others deliberately. Weighing a precursor against the coenzyme itself? Our NMN vs NAD+ comparison walks through it.

Sources

Educational information, not medical advice. Infinite Labs NMN is not intended to diagnose, treat, cure, or prevent any disease.

Keep it useful

Join the conversation